Brian Labadie
Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 14 | 0.770 |
Why?
| Kynurenine | 1 | 2018 | 19 | 0.760 |
Why?
| Tryptophan | 1 | 2018 | 88 | 0.730 |
Why?
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 45 | 0.720 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1207 | 0.680 |
Why?
| Schools | 1 | 2017 | 63 | 0.670 |
Why?
| Immunotherapy | 2 | 2019 | 572 | 0.660 |
Why?
| Gene Expression Profiling | 2 | 2019 | 1367 | 0.640 |
Why?
| Students | 1 | 2017 | 128 | 0.620 |
Why?
| Body Mass Index | 1 | 2019 | 783 | 0.610 |
Why?
| Carcinoma, Renal Cell | 1 | 2019 | 397 | 0.610 |
Why?
| Melanoma | 4 | 2021 | 504 | 0.580 |
Why?
| General Surgery | 1 | 2017 | 207 | 0.570 |
Why?
| Kidney Neoplasms | 1 | 2019 | 588 | 0.550 |
Why?
| Uveal Neoplasms | 2 | 2021 | 23 | 0.420 |
Why?
| Signal Transduction | 1 | 2018 | 3297 | 0.340 |
Why?
| Neoplasms | 1 | 2018 | 2672 | 0.270 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 2309 | 0.200 |
Why?
| Immunomodulation | 1 | 2018 | 57 | 0.190 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2019 | 160 | 0.180 |
Why?
| Databases, Genetic | 1 | 2019 | 259 | 0.180 |
Why?
| Organizational Innovation | 1 | 2017 | 36 | 0.170 |
Why?
| Protoporphyrins | 1 | 2017 | 20 | 0.170 |
Why?
| Aminolevulinic Acid | 1 | 2017 | 22 | 0.170 |
Why?
| California | 1 | 2017 | 135 | 0.170 |
Why?
| Keratosis, Actinic | 1 | 2017 | 13 | 0.170 |
Why?
| Neovascularization, Pathologic | 1 | 2019 | 356 | 0.170 |
Why?
| Photosensitizing Agents | 1 | 2017 | 47 | 0.170 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 900 | 0.170 |
Why?
| Program Development | 1 | 2017 | 136 | 0.160 |
Why?
| Photochemotherapy | 1 | 2017 | 99 | 0.160 |
Why?
| Skin Neoplasms | 1 | 2021 | 538 | 0.150 |
Why?
| Program Evaluation | 1 | 2017 | 301 | 0.150 |
Why?
| Career Choice | 1 | 2017 | 139 | 0.150 |
Why?
| Adolescent | 2 | 2019 | 9120 | 0.150 |
Why?
| Enzyme Inhibitors | 1 | 2018 | 674 | 0.150 |
Why?
| Disease Progression | 1 | 2019 | 1470 | 0.140 |
Why?
| Computational Biology | 1 | 2018 | 529 | 0.140 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 937 | 0.140 |
Why?
| Aged, 80 and over | 3 | 2021 | 6577 | 0.140 |
Why?
| Transcriptome | 1 | 2018 | 508 | 0.140 |
Why?
| Curriculum | 1 | 2017 | 469 | 0.130 |
Why?
| T-Lymphocytes | 1 | 2019 | 1287 | 0.120 |
Why?
| Cell Line, Tumor | 1 | 2018 | 2422 | 0.120 |
Why?
| Humans | 8 | 2021 | 83081 | 0.110 |
Why?
| Models, Biological | 1 | 2018 | 1797 | 0.110 |
Why?
| Cohort Studies | 1 | 2017 | 2704 | 0.110 |
Why?
| Male | 5 | 2021 | 41844 | 0.100 |
Why?
| Prognosis | 1 | 2018 | 3698 | 0.100 |
Why?
| Treatment Outcome | 2 | 2019 | 7886 | 0.100 |
Why?
| Female | 4 | 2021 | 44708 | 0.090 |
Why?
| Aged | 3 | 2021 | 18483 | 0.090 |
Why?
| Middle Aged | 4 | 2021 | 25586 | 0.090 |
Why?
| Mutation | 1 | 2019 | 3853 | 0.090 |
Why?
| Young Adult | 1 | 2019 | 5959 | 0.080 |
Why?
| Adult | 3 | 2021 | 25955 | 0.080 |
Why?
| Neoplasm Metastasis | 2 | 2021 | 1046 | 0.080 |
Why?
| Retrospective Studies | 1 | 2017 | 7599 | 0.070 |
Why?
| Anilides | 1 | 2019 | 47 | 0.050 |
Why?
| Dacarbazine | 1 | 2019 | 112 | 0.050 |
Why?
| Transfection | 1 | 2021 | 943 | 0.050 |
Why?
| Sunlight | 1 | 2017 | 30 | 0.040 |
Why?
| Pyridines | 1 | 2019 | 307 | 0.040 |
Why?
| Scalp | 1 | 2017 | 73 | 0.040 |
Why?
| Survival Analysis | 1 | 2021 | 1585 | 0.040 |
Why?
| Face | 1 | 2017 | 128 | 0.040 |
Why?
| Pain | 1 | 2017 | 360 | 0.030 |
Why?
| Time Factors | 1 | 2017 | 5497 | 0.020 |
Why?
|
|
Labadie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|